Bod Australia (ASX: BDA)
Bod Australia (ASX: BDA) operates a skin care and natural medicines business focused on all natural, evidence based products. www.bodaustralia.com
Bod Australia reveals ‘significant’ growth in medicinal cannabis prescriptions, more to come
Bod Australia (ASX: BDA) revealed this morning it has experienced “significant growth” in prescriptions for its medicinal...
Bod Australia receives major capital boost via Health & Happiness Group’s innovation arm
Cannabis-focused healthcare company Bod Australia (ASX: BDA) has struck an exclusive agreement with investment fund NewH2 owned by...
Bod Australia’s cannabis oil to be used in landmark PTSD trial
Cannabis-focused healthcare company Bod Australia (ASX: BDA) has announced it will supply its pharmaceutical-grade cannabis extract MediCabilis...
Clinical trial highlights tolerability of Bod Australia’s medicinal cannabis product
A phase one clinical trial of a sublingual cannabis wafer developed by Bod Australia (ASX: BDA) has...
Bod Australia posts record quarterly revenue thanks to new products, distribution deals
Skincare and health products developer Bod Australia (ASX: BDA) has posted a record revenue of $1.22 million...
Bod Australia gets green light to export growing medicinal cannabis product range
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has received the green light to export its...
Chemist Warehouse adds Bod Australia’s cannabis oil MediCabilis to its shelves
Australia’s adoption of medicinal cannabis has taken another step forward after Bod Australia (ASX: BDA) announced it...
Cannabis Access Clinics looks to aid Australian patient access to medical cannabis
The theory behind medical cannabis is that it has the potential to soothe many of today’s ailments,...
Bod Australia hits major milestone in cannabis wafer trial
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has achieved what it calls a “world-first” in...
Bod Australia kicks off phase 1 clinical trial for phytocomplex cannabis extract
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has stormed into a phase 1 clinical trial to test...
Bod Australia recruits Swisse director alongside growing medical cannabis trend
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has appointed a new executive chairman to spearhead its multifaceted growth...
Bod Australia receives early green light to commence cannabis clinical trial
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has surprised the market by announcing that it has secured ethics...
Bod Australia sets the stage for marketing medical cannabis oil in Australia
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added yet another string to its commercial...
Bod Australia obtains improved place in shop window via Australian Pharmaceuticals Industries
One of Australia’s emergent developer and distributors of cosmetics and natural medicines, Bod Australia (ASX: BDA) has...
Bod Australia gains approval to commence importing medicinal cannabis oil
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added another piece to its puzzle towards...
Bod Australia upscales natural medicines range in tandem with growing demand
Cosmetics-maker Bod Australia (ASX: BDA) has decided to upscale its sales and distribution efforts courtesy of a...
Bod to develop hemp-based manuka honey for global markets with Manuka Pharma
Bod Australia (ASX: BDA) will develop a hemp-based, high methylglyoxal manuka honey line to distribute to global...
Bod partners with iX Biopharma to incorporate medicinal cannabis in WaferiX for trials
Bod Australia (ASX: BDA) has agreed to supply its medicinal cannabis extracts to speciality pharmaceutical company iX...
Bod Australia kicks off cannabis-based cosmetic development, anticipates 2018 market release
Bod Australia (ASX: BDA) and Linnea SA have kicked off exploratory work into developing cannabis-based formulas for...